NewEdge Advisors LLC Increases Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI)

NewEdge Advisors LLC grew its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 1.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 35,662 shares of the exchange traded fund’s stock after acquiring an additional 548 shares during the period. NewEdge Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $3,212,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Howard Capital Management Group LLC lifted its holdings in SPDR S&P Biotech ETF by 2.6% in the third quarter. Howard Capital Management Group LLC now owns 248,114 shares of the exchange traded fund’s stock valued at $24,514,000 after acquiring an additional 6,188 shares during the period. Invst LLC lifted its stake in shares of SPDR S&P Biotech ETF by 6.0% in the third quarter. Invst LLC now owns 2,807 shares of the exchange traded fund’s stock valued at $277,000 after purchasing an additional 160 shares during the period. Westside Investment Management Inc. boosted its holdings in SPDR S&P Biotech ETF by 3.4% during the third quarter. Westside Investment Management Inc. now owns 6,170 shares of the exchange traded fund’s stock worth $610,000 after buying an additional 200 shares in the last quarter. Pine Valley Investments Ltd Liability Co grew its position in SPDR S&P Biotech ETF by 33.0% during the third quarter. Pine Valley Investments Ltd Liability Co now owns 10,387 shares of the exchange traded fund’s stock worth $1,026,000 after buying an additional 2,577 shares during the period. Finally, Synovus Financial Corp increased its holdings in SPDR S&P Biotech ETF by 110.9% in the third quarter. Synovus Financial Corp now owns 9,391 shares of the exchange traded fund’s stock valued at $928,000 after buying an additional 4,939 shares in the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of NYSEARCA:XBI opened at $75.93 on Monday. The firm has a market capitalization of $4.79 billion, a price-to-earnings ratio of 11.47 and a beta of 1.00. The business’s 50 day simple moving average is $83.76 and its 200-day simple moving average is $91.07. SPDR S&P Biotech ETF has a 12 month low of $66.66 and a 12 month high of $105.47.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.